This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...
US FDA staff ... over the therapy's benefits and risks by the U.S. Food and Drug Administration's advisory panel on Tuesday, ...
In almost a decade since AstraZeneca fended off a takeover by U.S. rival Pfizer, CEO Pascal Soriot ... leaps like artificial intelligence. US FDA staff raise concerns over data from J&J, Bristol's CAR ...